References
- DeGaetani M, Tennyson CA, Lebwohl B, Lewis SK, Abu Daya H, Arguelles-Grande C, et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 2013;108:647–53.
- Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol 2000;35:785–90.
- Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009;136:81–90.
- Weinstein WM, Saunders DR, Tytgat GN, Rubin CE. Collagenous sprue—an unrecognized type of malabsorption. N Engl J Med 1970;283:1297–301.
- Martucci S, Biagi F, Di Sabatino A, Corazza GR. Coeliac disease. Dig Liver Dis 2002;34(Suppl. 2):S150–3
- Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult coeliac disease – guidelines from the British Society of Gastroenterology. Gut 2014;63:1210–28.
- Biagi F, Corazza GR. Defining “gluten refractory enteropathy”. Eur J Gastroenterol Hepat 2001;13:561–5.
- Corazza GR, Biagi F, Volta U, Andreani ML, De Franceschi L, Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997;350:106–9.
- Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol 2007;5:1282–90.
- Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010;105:2262–75.
- Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol 2012;138:185–9.
- Boscá MM, Añón R, Mayordomo E, Villagrasa R, Balza N, Amorós C, et al. Methotrexate induced sprue-like syndrome. World J Gastroenterol 2008;14:7009–11.
- Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int 2004;17:463–7.
- Ziegler TR, Fernández-Estívariz C, Gu LH, Fried MW, Leader LM. Severe villous atrophy and chronic malabsorption induced by azathioprine. Gastroenterology 2003;124:1950–7.
- Green PH, Tall AR. Drugs, alcohol and malabsorption. Am J Med 1979;67:1066–76.
- Peacey SR, Walls WD. Steatorrhoea and sub-total villous atrophy complicating mefenamic acid therapy. Br J Clin Pract 1992;46:211.
- Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012;87:732–8.
- Scott LJ, McCormack PL. Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs 2008;68:1239–72.
- Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011;364:907–17.
- Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, et al. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol 2008;97:418–31.
- Hartranft ME, Regal RE. A story with one happy ending: “triple phase” budesonide capsules for the treatment of olmesartan-induced enteropathy. Ann Pharmacother 2014;48:1234–7.
- Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, et al. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther 2014;40:1103–9.
- Dedeoglu F. Drug-induced autoimmunity. Curr Opin Rheumatol 2009;21:547–51.
- Chang C, Gershwin ME. Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf 2011;34:357–74.
- Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med 2013;126:342–8.
- Ianiro G, Bibbò S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther 2014;40:16–23.
- Herman M, Rubio-Tapia A, Marietta E; Wu TT, Murray J. Severe enteropathy in a patient on valsartan. Am J Gastroenterol 2013;108:S302.
- Cyrany J, Vasatko T, Machac J, Nova M, Szanyi J, Kopacova M. Letter: telmisartan-associated enteropathy - is there any class effect? Aliment Pharmacol Ther 2014;40:569–70.